patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug
pentostatin
Marketedupdated 2mo agoby Hikma Pharmaceuticals USA Inc
Approvedcommunity read0 votes
all catalysts(12)
approval · 12
Oct 11, 1991
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Sep 29, 1993
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Jul 19, 1994
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Dec 24, 1997
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Oct 8, 1998
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Aug 2, 2001
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
May 23, 2002
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Sep 22, 2009
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Jun 20, 2013
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Dec 29, 2015
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Oct 28, 2019
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
Nov 3, 2025
approval
NIPENT (PENTOSTATIN) — FDA approval
pentostatin
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that